Recruiting NCT02869607
Institut Paoli Calmettes Breast Cancer Database
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Data collection.
- Who it may be relevant to
- Registry conditions: Breast Cancer Diagnosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Database of Institut Paoli-Calmettes patients diagnosed with breast cancer
Interventions
- Other Data collection
Primary outcome measures
- Survival of patients with breast cancer [Time frame: 10 years]
Secondary outcome measures (1)
- Collection of patients characteristics [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- Patient with a diagnosis of breast cancer
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Institut Paoli Calmettes — Marseille
Publications
- Houvenaeghel G, de Nonneville A, Cohen M, Sabiani L, Buttarelli M, Charaffe E, Jalaguier A, Bannier M, Tallet A, Viret F, Goncalves A. Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival. Cancer Med. 2024 Feb;13(3):e6930. doi: 10.1002/cam4.6930. Epub 2024 Feb 7. PMID 38327130
- Houvenaeghel G, de Nonneville A, Cohen M, Chopin N, Coutant C, Reyal F, Mazouni C, Gimbergues P, Azuar AS, Chauvet MP, Classe JM, Darai E, Martinez A, Rouzier R, de Lara CT, Lambaudie E, Barrou J, Goncalves A. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆. ESMO Open. 2021 Jun;6(3):100151. doi PMID 33984674
Identifiers
NCT: NCT02869607 · BDD-SEIN-IPC